Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONDOR study of induction TPF followed by chemoradiotherapy in locally advanced head and neck squamous cell carcinoma
2008-002308-24Phase 2Active
- Sponsor
- Radboud University Medical Center
- Start
- May 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of docetaxel, cisplatin and fluorouracil in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Feasibility and Toxicity profile. Started May 2008; status: active.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2008-002308-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002308-24.